Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Open-label, Multi-center Follow-up Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

NCT01106482 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01106482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Open-label, Multi-center Follow-up Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Lead sponsor
Novartis Vaccines
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
May 31, 2011
Enrollment
126 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

tick borne encephalitis (tbe)